Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Find effective ways to make income fast that fit your lifestyle. Start taking advantage of these opportunities today.
17,894 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
A couple earning about $150k aims to gift experiences to each other without secret money. A transparent, dedicated ‘s...
A steep 2026 selloff has investors weighing Microsoft through a new lens. This guide breaks down the case for microso...
A major tech firm is aggressively buying back shares while insiders pile in. This article breaks down what it signals...
Tech shares wobble as regulatory headlines hit the tape. This piece breaks down the Snap slump, regulatory risks from...
Among the market’s biggest names, only a few of the so-called magnficent seven look like buys today. This piece digs ...
Williams Companies positions its gas and power assets to benefit from the rapid expansion of AI data centers, signali...
A strong first quarter and solid cash generation helped CVS Health's shares spark on Wednesday. This guide breaks dow...
Palantir just beat earnings, yet its stock fell in after-hours trading as traders priced in slower growth and macro h...
A bizarre online listing claims a desk art piece tied to Epstein. This article explores the business case, ethics, an...
In Moscow, a scaled-back Victory Day parade marked by the absence of tanks and missiles. Markets react as analysts we...
If you’re wondering should apple stock before June 8, you’re not alone. This guide breaks down the catalysts, risks, ...